Pharma Matters Q&A: Alfasigma
A Q&A with Rocco Paracchini, director of Alfasigma’s CDMO business unit, about trends in the Italian CDMO market.
As (bio)pharma companies continue to focus on their core competencies they continue to rely on contract manufacturing organizations (CMOs).